New research is adding support to the controversial theory that Mycobacterium avium subspecies paratuberculosis (MAP) can cause Crohn’s disease.
Results from the randomized, placebo-controlled, phase 3 trial in patients with moderate to severe Crohn’s showed significantly more patients receiving antibiotic treatment targeting MAP experienced clinical remission or response after 16, 26 and 52 weeks.
“This study demonstrates that MAP is relevant to Crohn’s disease, and